Table 1 Correlation between XLF expression and clinicopathologic features in TACE-treated HCC
From: XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance
Clinical features | XLF expression | Â | P | |
|---|---|---|---|---|
Low | High | |||
Venous infiltration | (−) (+) | 11 2 | 7 11 | 0.025* |
Size of tumor (cm) | ≤5 >5 | 9 4 | 5 13 | 0.022* |
No. of nodules | Single Multiple | 6 7 | 8 10 | 0.925 |
UICC grade | I, II IIIa, IIIb | 12 1 | 10 8 | 0.045* |
Recurrence | (−) (+) | 6 7 | 6 12 | 0.47 |